CD47: A new player in phagocytosis and xenograft rejection

Cellular and Molecular Immunology

Volumn 8, Issue 4, 2011, Pages 285-288

  Navarro Alvarez, Nalu ^a   Yang, Yong Guang ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

CD47; macrophage; signal regulatory protein alpha; xenotransplantation

Indexed keywords

CD47 ANTIGEN; MEMBRANE PROTEIN; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; SIGNAL REGULATORY PROTEIN ALPHA; UNCLASSIFIED DRUG;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APOPTOSIS; ARTICLE; CELL COMMUNICATION; CYTOKINE PRODUCTION; ENGRAFTMENT; GENETIC POLYMORPHISM; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; OVERALL SURVIVAL; PHAGOCYTOSIS; PROGNOSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; ANTIGENS, CD47; GRAFT REJECTION; HUMANS; PHAGOCYTOSIS; TRANSPLANTATION, HETEROLOGOUS;

SUIDAE;

EID: 79960044264     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2010.83     Document Type: Article

References (58)

1. Yang YG, Sykes M. Xenotransplantation: current status and a perspective on the future. Nat Rev Immunol 2007; 7: 519-531. (Pubitemid 46987781)
2. Cooper DK, Gollackner B, Sachs DH. Will the pig solve the transplantation backlog? Annu Rev Med 2002; 53: 133-147. (Pubitemid 34177875)
3. Lai L, Kolber-Simonds D, Park KW, Cheong HT, Greenstein JL, Im GS et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295: 1089-1092. (Pubitemid 34132242)
4. Dai Y, Vaught TD, Boone J, Chen SH, Phelps CJ, Ball S et al. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 2002; 20: 251-255. (Pubitemid 34205417)
5. Kuwaki K, Tseng YL, Dor FJ, Shimizu A, Houser SL, Sanderson TM et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005; 11: 29-31. (Pubitemid 40215833)
6. Phelps CJ, Koike C, Vaught TD, Boone J, Wells KD, Chen SH et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003; 299: 411-414.
7. Yamada K, Yazawa K, Shimizu A, Iwanaga T, Hisashi Y, Nuhn M et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005; 11: 32-34. (Pubitemid 40215834)
8. Chen G, Qian H, Starzl T, Sun H, Garcia B, Wang X et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 2005; 11: 1295-1298. (Pubitemid 41752909)
9. Habiro K, Sykes M, Yang YG. Induction of human T-cell tolerance to pig xenoantigens via thymus transplantation in mice with an established human immune system. Am J Transplant 2009; 9: 1324-1329.
10. Dwyer KM, Robson SC, Nandurkar HH, Campbell DJ, Gock H, Murray-Segal LJ et al. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest 2004; 113: 1440-1446. (Pubitemid 39071699)
11. Watier H, Guillaumin JM, Vallee I, Thibault G, Gruel Y, Lebranchu Y et al. Human NK cell-mediated direct and IgG-dependent cytotoxicity against xenogeneic porcine endothelial cells. Transpl Immunol 1996; 4: 293-299. (Pubitemid 27019623)
12. Kumagai-Braesch M, Satake M, Qian Y, Holgersson J, Moller E. Human NK cell and ADCC reactivity against xenogeneic porcine target cells including fetal porcine islet cells. Xenotransplantation 1998; 5: 132-145. (Pubitemid 28198080)
13. Sasaki H, Xu XC, Smith DM, Howard T, Mohanakumar T. HLA-G expression protects porcine endothelial cells against natural killer cell-mediated xenogeneic cytotoxicity. Transplantation 1999; 67: 31-37. (Pubitemid 29061133)
14. Oldenborg PA, Zheleznyak A, Fang YF, Lagenaur CF, Gresham HD, Lindberg FP. Role of CD47 as a marker of self on red blood cells. Science 2000; 288: 2051-2054. (Pubitemid 30397687)
15. Blazar BR, Lindberg FP, Ingulli E, Panoskaltsis-Mortari A, Oldenborg PA, Iizuka K et al. CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells. J Exp Med 2001; 194: 541-549. (Pubitemid 32835048)
16. Lindberg FP, Gresham HD, Schwarz E, Brown EJ. Molecular cloning of integrinassociated protein: an immunoglobulin family member with multiple membranespanning domains implicated in alpha v beta 3-dependent ligand binding. J Cell Biol 1993; 123: 485-496. (Pubitemid 23313971)
17. Brown E, Hooper L, Ho T, Gresham H. Integrin-associated protein: a 50-kD plasma membrane antigen physically and functionally associated with integrins. J Cell Biol 1990; 111: 2785-2794. (Pubitemid 120014559)
18. Jiang P, Lagenaur CF, Narayanan V. Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J Biol Chem 1999; 274: 559-562.
19. Brown EJ, Frazier WA. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol 2001; 11: 130-135. (Pubitemid 32289443)
20. Babic I, Schallhorn A, Lindberg FP, Jirik FR. SHPS-1 induces aggregation of Ba/F3 pro-B cells via an interaction with CD47. J Immunol 2000; 164: 3652-3658. (Pubitemid 30169819)
21. Adams S, van der Laan LJ, Vernon-Wilson E, Renardel de Lavalette C, Dopp EA, Dijkstra CD et al. Signal-regulatory protein is selectively expressed by myeloid and neuronal cells. J Immunol 1998; 161: 1853-1859. (Pubitemid 28387606)
22. Seiffert M, Brossart P, Cant C, Cella M, Colonna M, BruggerW et al. Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD341CD382 hematopoietic cells. Blood 2001; 97: 2741-2749.
23. Kharitonenkov A, Chen Z, Sures I, Wang H, Schilling J, Ullrich A. A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature 1997; 386: 181-186. (Pubitemid 27131446)
24. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-964. (Pubitemid 41746764)
25. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell 2002; 111: 927-930. (Pubitemid 36044685)
26. Barclay AN, Brown MH. The SIRP family of receptors and immune regulation. Nat Rev Immunol 2006; 6: 457-464.
27. Ishikawa-Sekigami T, Kaneko Y, Okazawa H, Tomizawa T, Okajo J, Saito Y et al. SHPS-promotes the survival of circulating erythrocytes through inhibition of phagocytosis by splenic macrophages. Blood 2006; 107: 341-348. (Pubitemid 43053561)
28. Yamao T, Noguchi T, Takeuchi O, Nishiyama U, Morita H, Hagiwara T et al. Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1. J Biol Chem 2002; 277: 39833-39839.
29. Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, Murphy-Ullrich JE et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 2005; 123: 321-334. (Pubitemid 41457220)
30. Allen LB, Capps BE, Miller EC, Clemmons DR, Maile LA. Glucose-oxidized low-density lipoproteins enhance insulin-like growth factor I-stimulated smooth muscle cell proliferation by inhibiting integrin-associated protein cleavage. Endocrinology 2009; 150: 1321-1329.
31. Alblas J, Honing H, de Lavalette CR, Brown MH, Dijkstra CD, van den Berg TK. Signal regulatory protein alpha ligation induces macrophage nitric oxide production through JAK/STAT- and phosphatidylinositol 3-kinase/Rac1/NAPDH oxidase/H2O2- dependent pathways. Mol Cell Biol 2005; 25: 7181-7192. (Pubitemid 41105914)
32. Latour S, Tanaka H, Demeure C, Mateo V, Rubio M, Brown EJ et al. Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation. J Immunol 2001; 167: 2547-2554. (Pubitemid 32768881)
33. Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, Majeti R et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 2009; 138: 271-285.
34. Tsai RK, Discher DE. Inhibition of "self" engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. J Cell Biol 2008; 180: 989-1003. (Pubitemid 351398424)
35. Kong XN, Yan HX, Chen L, Dong LW, Yang W, Liu Q, et al. LPS-induced down-regulation of signal regulatory protein {alpha} contributes to innate immune activation in macrophages. J Exp Med 2007; 204: 2719-2731. (Pubitemid 350044794)
36. Majeti R, Chao MP, Alizadeh AA, Pang WW, Jaiswal S, Gibbs KD Jr et al. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 2009; 138: 286-299.
37. Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn- Khosrovani S, Boer JM et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004; 350: 1617-1628. (Pubitemid 38528701)
38. Uno S, Kinoshita Y, Azuma Y, Tsunenari T, Yoshimura Y, Iida S et al. Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia. Oncol Rep 2007; 17: 1189-1194.
39. Kikuchi Y, Uno S, Kinoshita Y, Yoshimura Y, Iida S, Wakahara Y et al. Apoptosis inducing bivalent single-chain antibody fragments against CD47 showed antitumor potency for multiple myeloma. Leuk Res 2005; 29: 445-450. (Pubitemid 40255819)
40. Mateo V, Lagneaux L, Bron D, Biron G, Armant M, Delespesse G et al. CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia. Nat Med 1999; 5: 1277-1284. (Pubitemid 29535605)
41. Chan KS, Espinosa I, Chao M, Wong D, Ailles L, Diehn M et al. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci USA 2009; 106: 14016-14021.
42. Kim MJ, Lee JC, Lee JJ, Kim S, Lee SG, Park SW et al. Association of CD47 with natural killer cell-mediated cytotoxicity of head-and-neck squamous cell carcinoma lines. Tumour Biol 2008; 29: 28-34. (Pubitemid 351733217)
43. Ide K, Ohdan H, Kobayashi T, Hara H, Ishiyama K, Asahara T. Antibody- and complement-independent phagocytotic and cytolytic activities of human macrophages toward porcine cells. Xenotransplantation 2005; 12: 181-188. (Pubitemid 40524978)
44. Wallgren AC, Karlsson-Parra A, Korsgren O. The main infiltrating cell in xenograft rejection is a CD41 macrophage and not a T lymphocyte. Transplantation 1995; 60: 594-601.
45. Wu G, Korsgren O, Zhang J, Song Z, van Rooijen N, Tibell A. Pig islet xenograft rejection is markedly delayed in macrophage-depleted mice: a study in streptozotocin diabetic animals. Xenotransplantation 2000; 7: 214-220.
46. Yi S, Hawthorne WJ, Lehnert AM, Ha H, Wong JK, van Rooijen N et al. T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts. J Immunol 2003; 170: 2750-2758. (Pubitemid 36245670)
47. Soderlund J, Wennberg L, Castanos-Velez E, Biberfeld P, Zhu S, Tibell A et al. Fetal porcine islet-like cell clusters transplanted to cynomolgus monkeys: an immunohistochemical study. Transplantation 1999; 67: 784-791. (Pubitemid 29169121)
48. Burlak C, Twining LM, Rees MA. Terminal sialic acid residues on human glycophorin A are recognized by porcine kupffer cells. Transplantation 2005; 80: 344-352. (Pubitemid 41129963)
49. Jin R, Greenwald A, Peterson MD, Waddell TK. Human monocytes recognize porcine endothelium via the interaction of galectin 3 and alpha-GAL. J Immunol 2006; 177: 1289-1295. (Pubitemid 44036635)
50. Wang H, VerHalen J, Madariaga ML, Xiang S, Wang S, Lan P et al. Attenuation of phagocytosis of xenogeneic cells by manipulating CD47. Blood 2007; 109: 836-842. (Pubitemid 46105989)
51. Ide K, Wang H, Tahara H, Liu J, Wang X, Asahara T et al. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages. Proc Natl Acad Sci USA 2007; 104: 5062-5066. (Pubitemid 47186176)
52. Abe M, Cheng J, Qi J, Glaser RM, Thall AD, Sykes M et al. Elimination of porcine hemopoietic cells by macrophages in mice. J Immunol 2002; 168: 621-628. (Pubitemid 34049561)
53. Subramanian S, Parthasarathy R, Sen S, Boder ET, Discher DE. Species- and cell typespecific interactions between CD47 and human SIRPalpha. Blood 2006; 107: 2548-2556. (Pubitemid 43348703)
54. Takenaka K, Prasolava TK, Wang JC, Mortin-Toth SM, Khalouei S, Gan OI et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol 2007; 8: 1313-1323. (Pubitemid 350138972)
55. Hatherley D, Harlos K, Dunlop DC, Stuart DI, Barclay AN. The structure of the macrophage signal regulatory protein alpha (SIRPalpha) inhibitory receptor reveals a binding face reminiscent of that used by T cell receptors. J Biol Chem 2007; 282: 14567-14575. (Pubitemid 47100437)
56. Sano S, Ohnishi H, Kubota M. Gene structure of mouse BIT/SHPS-1. Biochem J 1999; 344: 667-675. (Pubitemid 30032514)
57. Nakaishi A, Hirose M, Yoshimura M, Oneyama C, Saito K, Kuki N et al. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47. J Mol Biol 2008; 375: 650-660. (Pubitemid 350297294)
58. Wang Y, Wang H, Wang S, Fu Y, Yang YG. Survival and function of CD47-deficient thymic grafts in mice. Xenotransplantation 2010; 17: 160-165.